Publications by authors named "Michelle Ferguson"

Claim this Profile
D
Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer.
Ailith Ewing, Alison Meynert, Ryan Silk, Stuart Aitken, Devin P Bendixsen, Michelle Ferguson

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic BRCA1/2 mutations are associated with a similar survival advantage to their germline counterparts in tubo-ovarian high grade serous carcinoma.
Robert L Hollis, Michael Churchman, Graeme R Grimes, Alison M Meynert, Philippe Gautier, Michelle Ferguson

Eur J Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study.
Yvette Drew, Jae-Weon Kim, Richard T Penson, David M O'Malley, Christine Parkinson, Michelle Ferguson

Clin Cancer Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab monotherapy for non-small cell lung cancer (NSCLC): can patient stratification be improved in the UK Tayside population? A retrospective cohort study.
Emily Susannah Mander, Christopher Brian Merrick, Hugh Adam Nicholson, Hannah Kate Lord, Michelle Jane Ferguson

BMJ Open· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer.
Daniel E Spratt, Siyi Tang, Yilun Sun, Huei-Chung Huang, Emmalyn Chen, Michelle J Ferguson

NEJM Evid· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer.
Daniel E Spratt, Siyi Tang, Yilun Sun, Huei-Chung Huang, Emmalyn Chen, Michelle J Ferguson

Res Sq· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.
Andre Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, Jeffry P Simko, Michelle J Ferguson

NPJ Digit Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer.
Hugh A Nicholson, Lynne Sawers, Rosemary G Clarke, Kevin J Hiom, Michelle J Ferguson

Br J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.
Andre Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, Jeffry P Simko, Michelle J Ferguson

NPJ Digit Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural Variants at the Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma.
Ailith Ewing, Alison Meynert, Michael Churchman, Graeme R Grimes, Robert L Hollis, Michelle Ferguson

Clin Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland.
Holly M McCabe, Alannah Smrke, Fiona Cowie, Jeff White, Peter Chong, Michelle Ferguson

JCO Glob Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Value in Mental Health Screening for Individuals With Spinal Cord Injury: What Patients Tell Us.
Colleen McMillan, Joseph Lee, Loretta M Hillier, James Milligan, Linda Lee, Michelle Ferguson

Arch Rehabil Res Clin Transl· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virtual Reality-Based Resilience Programs: Feasibility and Implementation for Inpatient Oncology Nurses.
Sarah H Michael, Pamela M Villarreal, Michelle F Ferguson, Jennifer L Wiler, Richard D Zane

Clin J Oncol Nurs· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells.
Aparajitha Vaidyanathan, Lynne Sawers, Anne-Louise Gannon, Probir Chakravarty, Alison L Scott, Michelle J Ferguson

Br J Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1/2 Trial of Brief Androgen Suppression and Stereotactic Radiation Therapy (FASTR) for High-Risk Prostate Cancer.
Glenn Bauman, Michelle Ferguson, Michael Lock, Jeff Chen, Belal Ahmad

Int J Radiat Oncol Biol Phys· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of high-grade gliomas in the elderly.
Michelle Ferguson, George Rodrigues, Jeffrey Cao, Glenn Bauman

Semin Radiat Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging the communication gap between oncologists and patients receiving palliative therapies.
Michelle Ferguson, George Rodrigues

Ann Palliat Med· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late-onset meningeal metastases in liposarcoma: a case report and review of the literature.
Michelle Ferguson, William Stewart, Fiona Cowie, Jeff White

Sarcoma· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased incidence of visceral metastases in scottish patients with BRCA1/2-defective ovarian cancer: an extension of the ovarian BRCAness phenotype.
Charlie Gourley, Caroline O Michie, Patricia Roxburgh, Timothy A Yap, Sharon Harden, Michelle Ferguson

J Clin Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to death.
Michelle Ferguson, M Gloria Luciani, Lee Finlan, Elaine M Rankin, Sally Ibbotson

Cell Cycle· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis